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Summary
Background: The optimal timing of the initial echo- 
cardiographic assessment and the influence of micro- 
organisms on echocardiographic findings in patients 
with infective endocarditis (IE) are not well studied. 
Methods: In 274 patients with IE, we studied the 
impact of antibiotic treatment duration of ≤2 days 
(early, 119 patients) or >2 days (late, 144 patients) 
prior to diagnostic echocardiography on IE specific 
findings and on clinical outcomes. Results were strati-
fied for patients with Staphylococcus aureus (SA pa-
tients, n = 84) and those with other causative organ-
isms (non-SA patients, n = 190).
Results: There were no differences on specific echo-
cardiographic findings between patients with early 
versus late echocardiography: Presence of vegetations: 
91% vs 86%, p = 0.25; size of vegetations: 1.5 ± 0.7 cm 
vs 1.5 ± 0.8 cm, p = 0.83; paravalvular abscess: 24% 
vs 24%, p = 0.88, or valve destruction: 44% vs 35%, p = 
0.17. There were also no differences in terms of clinical 
outcomes between the two groups: Heart surgery for IE 
in 61% vs 53%, p = 0.21, and in-hospital death in 8% vs 
11%, p = 0.46. The presence of SA was not associated 
with specific findings on echocardiography or worse 
clinical outcomes compared to non-SA patients. 
Conclusions: In patients with infective endocardi-
tis, the findings of early vs late initial echocardio-
graphic assessment did not differ, and echocardio-
graphic findings did not allow inference on the causing 
organism. Neither the timing of the initial echocardio-
graphic study nor any organism involved was associ-
ated with clinical outcome. 
Key words: infective endocarditis; timing; echocar-
diography; outcome
Introduction
Infective endocarditis (IE) is a life 
threatening condition with in-hos-
pital mortality rates of 15%–20% 
[1–4]. Staphylococcus aureus (SA) 
has been identified as the most common causing micro-
organism in patients with IE (up to 31% of all patients 
with IE) and has been associated with worse outcomes 
compared to other microorganisms. In some series, pa-
tients with SA endocarditis had mortality rates of 
22%–40% for left sided native valve IE and up to 45% 
in prosthetic valve IE [5–7]. Early diagnosis and 
prompt initiation of adequate treatment is crucial for 
favourable outcomes [8]. 
While the initial management of IE is mainly 
guided by clinical findings and positive blood cultures, 
echocardiography is the cornerstone for confirmation 
of IE. In all patients with SA bacteraemia, trans- 
oesophageal echocardiography (TEE) is now indicated, 
due to its high accuracy in detecting IE [9, 10]. Al-
though there is no data on optimal timing of echo- 
cardiographic assessment in the case of suspected 
endocarditis, American and European Guidelines on 
management of IE recommend echocardiography at 
the earliest possible opportunity [5, 9]. However, in-
creasing overuse of echocardiography in the setting of 
suspected IE with low pre-test probability has been 
noted [11, 12]. 
The aims of this study were (1.) to study the influ-
ence of IE causing organisms, in particular that of SA, 
on echocardiographic findings, (2.) to analyse the im-
pact of timing of the initial echocardiographic assess-
ment on IE specific findings and (3.) to study the im-
pact of microorganisms as well as of timing of the ini-
tial echocardiography on outcome. 
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a prosthetic valve and/or newly detected valvular re-
gurgitation of ≥ moderate severity [17–19]. In all pa-
tients in whom vegetations were detected, their maxi-
mal length was measured. To assess the impact of 
echocardiographic timing on findings consistent with 
IE, patients were further divided into those with early 
(≤2 days of antibiotic treatment prior to the initial echo-
cardiographic study) and late assessment (>2 days of 
antibiotic treatment). In the absence of relevant litera-
ture, those time frames were chosen arbitrarily. They 
do however represent typical time frames often dis-
cussed in clinical practice. 
Clinical outcomes
We analysed the impact of timing of the initial echocar-
diographic assessment as well as of microorganisms 
causing IE on heart surgery for IE and on in-hospital 
death. Heart surgery for IE was further divided into 
early (within 6 weeks of the diagnosis) and late surgery.
Statistical analysis
Continuous variables are expressed as mean ± stan-
dard deviation or median and range, as appropriate. 
Categorical variables are expressed as number and 
percentage. For comparison between groups we used 
the independent sample T-test, the Mann-Whitney test 
or chi-square tests, as appropriate. For comparison of 
3 or more groups we performed one-way analysis of 
variance (ANOVA) with Duncan’s posthoc analysis or 
chi-square test. A two-sided p-value of <0.05 was con-
sidered statistically significant. Statistical analyses 
were performed using SPSS software (release 19, SPSS 
Inc., Chicago, Illinois). 
Results
Patient population
Of a total of 1,995 patients with suspected infective 
endocarditis referred for echocardiographic assess-
ment, 327 (16.3%) had findings confirming IE (flow 
chart fig. 1). 53 of these patients had to be excluded 
from analysis due to incomplete clinical data. The re-
maining 274 patients with clinical signs and echocar-
diographic findings confirming the diagnosis of IE and 
who were treated accordingly represent the study sub-
jects. 
Microbiological spectrum 
The spectrum of organisms involved is given in figure 
2. Of the 236 organisms, 224 (82%) were identified by 
blood cultures, while 12 (18%) were only detected by 
PCR or serological analyses. 
Clinical findings and Duke classification 
The baseline characteristics and specific findings for 
the Duke classification of the 274 patients in the study 
group are shown in table 1. Patients in the SA-group 
Methods
Patient population
All patients referred to our echocardiography labora-
tory for assessment of infective endocarditis between 
1995 and 2011 were identified from our prospective 
echocardiography database. Only patients with echo-
cardiographic findings confirming the diagnosis of IE 
comprised the study group.
Clinical and laboratory data
Baseline clinical and demographic variables as well 
as information on outcomes were derived from chart 
review. For all patients the onset of typical symptoms 
and signs of IE (fever >38 °C, typical vascular and im-
munological findings) as well as the time of initiation 
of antibiotic treatment prior to the first echocardio-
graphic examination were carefully assessed. Com-
plete blood count, C-reactive protein levels and serum 
creatinine levels at hospital admission were recorded. 
We also reviewed computed tomography exams that 
were performed within 72 hours of hospital admission 
for evidence of systemic or (in the case of right-sided 
IE) infective pulmonary embolisms. The risk factors for 
IE included pre-existing valvular heart disease, intra-
venous drug abuse, immunosuppressive drug therapy, 
diabetes mellitus, human immunodeficiency virus 
(HIV) infection and the presence of central venous 
catheters [9]. Based on clinical, laboratory, microbiol-
ogy and echocardiographic findings the modified Duke 
criteria were applied to all study subjects [13, 14]. 
Microbiology data
Data of isolated microorganisms were derived from 
blood cultures, broad-range polymerase chain reaction 
[15, 16] performed on postoperative valve material as 
well as from serological testing. If more than one type 
of microorganism had been isolated, the most likely IE 
causing organism was determined by an infectious dis-
ease specialist. Special attention was paid to the incu-
bation time of blood cultures and the time that had 
elapsed between positive blood cultures and the echo-
cardiographic study. For the purpose of this study 
patients were grouped in those with Staphylococcus 
aureus (SA patients) and those with other microorgan-
isms (non-SA patients) causing IE.
Echocardiography
Transthoracic (TTE) and/or transoesophageal echocar-
diography (TEE) were used according to clinical setting 
and image quality. When typical findings of IE were 
identified on TTE in clinically stable patients TEE was 
not necessarily performed [9]. Findings consistent with 
IE were vegetations (defined as oscillating intracardiac 
masses on a valvular structure, in the path of regurgi-
tant jets or on implanted prosthetic material), valvular 
and paravalvular abscesses, novel partial dehiscence of 
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sification, 214 (78%) patients would have been classi-
fied as definite IE. The remaining 60 (22%) patients 
qualified as ”possible IE”, including the 38 (14%) pa-
tients with unidentified microorganism. However, all 
patients who were analysed in this study were clini-
cally considered to have IE and received a full course of 
antibiotics. 
Time course of IE
Compared to the non-SA group, SA patients had a 
shorter time interval from first clinical signs to diagno-
sis (9 [1–30] days vs 14 [1–180] days, p <0.001) and 
shorter blood culture incubation times (1 [1–3] days vs 
2 [0–34] days, p <0.001). However, once the diagnosis 
was confirmed by echocardiogra-
phy, the time to the clinical end-
points (in-hospital death and heart 
surgery for IE) did not differ signif-
icantly between the two groups. 
Influence of microorganisms 
on echocardiographic findings 
(table 2)
More SA infections were found in 
native tricuspid valves (p = 0.01), 
whereas overall prosthetic valve IE 
was more often caused by non-SA 
organisms (p = 0.006). Paravalvu-
lar abscess formation in patients 
with prosthetic valves was the only 
IE specific finding more common 
in the non-SA group compared to 
the SA group (p = 0.04, most often 
caused by Enterococcus species). 
All other findings were not signifi-
cantly different between the SA 
and the non-SA groups. Figure 3 il-
lustrates the heterogeneous ap-
pearances of IE specific findings 
caused by the same microorganism 
(panel 1A/B, 2A/B and 3A/B), and 
the homogenous appearances of 
findings caused by different micro-
organisms (panel 4A/B). 
Early vs late initial  
echocardiographic assessment
The duration of antibiotic therapy 
before the initial echocardiographic 
assessment had no significant im-
pact on IE specific findings on echo-
cardiography (table 3). Sub-analy-
ses for the 57 patients who had no 
antibiotic treatment at all before 
their initial echocardiographic 
study did not reveal significant dif-
ferences in echocardiographic find-
had higher CRP and creatinine levels (both p <0.001) 
as well as more vascular (embolic) complications (p = 
0.001) at initial presentation and were more likely to 
have a history of fever (p = 0.02). When the study pop-
ulation was divided into those with early vs late echo-
cardiographic assessment, the baseline characteristics 
as in table 1 did not significantly differ between the two 
groups, with the only exception of the leucocyte count 
(early: 12,800 ± 7,100/μl vs late: 10,900 ± 5,700/μl, p = 
0.02).
Since the presence of echocardiographic findings 
consistent with IE was an inclusion criterion for this 
study, all patients had at least one, and 66% had two 
major Duke criteria. Based on the modified Duke clas-
Figure 1
Flow chart of patient population.
Figure 2
Overview of IE causing organisms (n = 236).
Blue colour = Staphylococcus aures patients; green colour = non-Staphylococcus aureus 
patients ; HACEK = Haemophilus, Actinobacillus, Cardiobacterium hominis, Eikenella, Kingella.
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Patients with an initially false negative study 
In the nine patients in whom typical findings of IE 
were detected only on follow-up echocardiography, veg-
etations were smaller compared to those with vegeta-
tions on their initial echocardiographic study (0.7 cm 
vs 1.6 cm, p = 0.04), and fewer had new significant val-
vular regurgitation (44% vs 79%, p = 0.01). All other 
echocardiographic findings, organisms involved as well 
as clinical outcomes were not different compared to 
those with typical findings on their initial echocardiog-
raphy. 
Discussion
In 274 patients with acute infective endocarditis (IE) 
the initial echocardiographic findings were not specific 
for Staphylocouccus aureus (SA) or any other organ-
isms, and the outcome did not differ between SA and 
non-SA patients. Early vs late initial echocardio-
ings compared to those who had prior antibiotic treat-
ment. 
Influences of microorganisms and timing of 
echocardiography on outcome 
26 patients (10%) died during the index hospital stay, 
and heart valve surgery was required in 151 (55%) of 
patients (110 or 40% were performed early). The out-
come of SA patients in terms of the need for heart sur-
gery (51% vs 57%, p = 0.32), the need for early heart 
surgery for IE (35% vs. 43%, p = .21) or the rate of in-
hospital deaths (13% vs 8%, p = 0.18) was not signifi-
cantly different from patients with non-SA IE. Even 
when analysing all identified microorganisms sepa-
rately, no single organism was associated with better 
or worse clinical outcome. Furthermore, the duration 
of antibiotic treatment (0–2 days or >2 days) before the 
initial echocardiographic assessment was not associ-
ated with different clinical outcome (table 3).
Table 1
Baseline characteristics of the study population (n = 274).
 
 
All patients
(n = 274)
SA group
(n = 84)
Non-SA group
(n = 190) 
 
p
Mean age (years) 53 ± 17 50 ± 6 53 ± 6 0.19
Women, n (%) 70 (26) 18 (21) 52 (27) 0.30
Clinical sings of infective endocarditis
Fever (>38 °C) 206 (75) 71 (85) 135 (71) 0.02
Vascular complications
a
141 (52) 56 (67) 85 (45) 0.001
Cerebral complications n (%) 70 (26) 33 (39) 37 (20) <0.001
Immunologic complications
b
21 (8) 6 (7) 15 (8) 0.83
Laboratory findings 
Leucocyte count (10
3
/μl) 11.6 ± 6.3 11.8 ± 7.3 11.5 ± 5.8 0.71
Thrombocyte count (10
3
/μl) 226 181 (14–755) 237 (6–1601) 0.007
C-reactive protein (mg/l) 100 155 (3–508) 81 (1–384) <0.001
Creatinine (μmol/l) 96 115 (49–526) 91 (44–767) <0.001
Clinical risk factors for IE
Previous valve surgery 59 (22) 13 (16) 46 (24) 0.11
Intravenous drug abuse, n (%) 52 (19) 31 (37) 21 (11) <0.001
Diabetes mellitus, n (%) 35 (13) 17 (20) 18 (10) 0.01
HIV, n (%) 22 (8) 11 (13) 11 (6) 0.04
Central venous catheter, n (%) 18 (7) 6 (7) 12 (6) 0.80
Immunosuppressive therapy, n (%) 10 (4) 5 (6) 5 (3) 0.17
Timing of initial echocardiography
Days of antibiotic use before echo 3 (0–50) 4 (0–50) 3 (0–34) 0.17
Early infection
c
 post OP: days to echo 95 (18–180) 99 (55–180) 95 (18–179) 0.53
Late infection
c
 post OP: years to echo 6.4 (0.7–44.6) 9.0 (0.9–22) 5.4 (0.7–44.6) 0.18
Echocardiographic modality used 
TTE only, n (%) 121 (44) 37 (44) 84 (44) 0.10
TEE only, n (%) 62 (23) 25 (30) 37 (20) 0.10
TTE and TEE, n (%) 91 (33) 22 (26) 69 (36) 0.10
IE = infective endocarditis; SA = Staphylococcus aureus.
a
 Vascular complications includes septic arterial embolisation (cerebral, abdominal, lungs) and Janeway lesions.
b
 Immunologic complications includes Osler nods, Roth’s spots and IE associated glomerulonephritis.
c
  Early and late infection post OP: defined as infective endocarditis occurring ≤ and > than 6 months post prior heart valve surgery, 
respectively.
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Table 2
Sites of infectious endocarditis and specific findings on echocardiography.
All patients SA goup Non-SA group p *
 (n = 274) (n = 84) (n = 190)  
Site of endocarditis
Native valve endocarditis
a
251 (92) 84 (100) 167 (88) 0.07
– Aortic, all 106 (39) 27 (32) 79 (42) 0.09
– Aortic, bicuspid 30 (11) 8 (10) 22 (12) 0.65
– Mitral 109 (40) 40 (48) 69 (36) 0.06
– Tricuspid 35 (13) 17 (20) 18 (9) 0.01
– Pulmonic 1 (<1) 0 (0) 1 (0.5) 0.51
Repaired mitral valve 9 (3) 5 (6) 4 (2) 0.09
Prosthetic valve endocarditis
a 
53 (19) 10 (12) 43 (22) 0.006
 – Mechanical prosthesis 28 (10) 6 (7) 22 (12) 0.28
 – Biological prosthesis 25 (9) 4 (5) 21 (11) 0.10
Pacemaker leads
b
6 (2) 2 (2) 4 (2) 0.30
Double valve endocarditis 45 (16) 17 (20) 28 (15) 0.23
Specific findings
Vegetations 242 (88) 79 (94) 163 (86) 0.05
 – Size of vegetations, cm 1.5 ± 0.8 1.7 ± 0.8 1.5 ± 0.7 0.32
Paravalvular abscess 64 (23) 17 (20) 47 (25) 0.42
 – Native valve 40 (15) 14 (17) 26 (14) 0.52
 – Prosthetic valve 24 (9) 3 (4) 21 (11) 0.04
Valve destruction 111 (41) 35 (42) 76 (40) 0.80
 – Chordal rupture 32 (12) 6 (7) 26 (4) 0.12
 – Leaflet or cusp rupture 15 (5) 4 (5) 11 (6) 0.73
 – Valve perforation 70 (26) 25 (30) 45 (24) 0.29
New insufficiency ≥moderate 214 (78) 63 (75) 151 (79) 0.41
a 
Including 45 double valve infective endocarditis (native and/or prosthetic): aortic + mitral valves (n = 33), aortic + tricuspid valves  
(n = 5), mitral + tricuspid valves (n = 5) and aortic + pulmonic valve (n = 2). 
b
 Including: 2 patients with isolated pacemaker IE, 2 patients with concomitant mechanical aortic prosthesis IE, 2 patients with  
concomitant native valve IE (1 × tricuspide valve, 1 × mitral valve). SA = Staphylococcus aureus.
graphic assessment with regards to the duration of 
prior antibiotic treatment was not associated with spe-
cific echocardiographic findings or clinical outcomes. 
Timing of the initial echocardiographic  
assessment
Little is known about the course of IE specific changes 
over time, and hence about the influence of timing of 
the initial echocardiographic assessment on findings or 
diagnosis of IE. American and European IE guidelines 
suggest “rapid” echocardiographic assessment in all 
patients with suspected IE but do not further specify 
the timeline [5, 9]. Indeed there is no evidence on the 
best timing of echocardiography in literature. It is how-
ever known that presence and size of vegetations are 
relatively stable over time; 70% of vegetations were 
still present at the end of the antibiotic treatment pe-
riod, and of these 59% did not show any difference in 
size [20]. Furthermore, the choice of antibiotic treat-
ment appears to influence the size of vegetations on se-
rial echocardiography; vancomycin-associated treat-
ment was related to a 45% reduction of vegetation size, 
while penicillin reduced vegetation size only by 5% 
[21]. In our study, IE specific findings were not signifi-
cantly different between patients with early (median of 
1 day of antibiotic treatment) or late echo assessment 
(median of 9 days), and late echocardiographic assess-
ment was not associated with a worse outcome. To the 
best of our knowledge, no similar data concerning tim-
ing of the initial echocardiographic study has been pub-
lished before. 
Patients with initially negative  
echocardiographic studies
Repeat echocardiography after 7–10 days is indicated 
in cases with initially negative findings and persistent 
clinical suspicion for IE [5]. However, there is only lim-
ited data on rates of and findings in repeat studies. In 
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ings in SA IE are not specific, and a considerable over-
lap exists for example with coagulase negative staphy-
lococcus [2]. In our study however, SA caused more tri-
cuspid valve IE compared non-SA patients, and 
significantly more non-SA patients had prosthetic 
valve infection and prosthetic paravalvular abscess 
formation compared to SA patients. While relevant dif-
ferences in echocardiographic findings can be found be-
tween SA and non-SA patients, none of the findings 
was specific for one of the groups, and therefore infer-
ence to the IE causing organism based on echocardio-
graphic findings is impossible. 
Clinical implications
Rapid performance of echocardiography in patients 
with IE is important to confirm the suspected diagno-
sis, to assess parameters that predict complications 
and guide management decisions in order to optimise 
outcome [3, 25–29]. But how rapid is rapid? While our 
study was not designed to give a definite answer to that 
question, our results indicate that short-term antibi-
otic treatment does not significantly alter the IE spe-
cific findings and hence does not influence the confir-
mation of IE. In addition, the time period of antibiotic 
the study of Sochowsky et al., repeat studies were pos-
itive in 3 out of 7 patients (43%) [22]. Features associ-
ated with initially negative studies included challeng-
ing echocardiographic conditions such as mitral valve 
prolapse, ruptured chords, presence of prosthetic 
valves, small vegetations mistaken for strands and SA 
endocarditis [10, 22, 23]. In our series, repeat studies 
confirmed IE in 9 out of 62 patients (15%), and vegeta-
tions of these patients were smaller compared to all 
other patients. This suggests that they grew later or 
might have been missed in the initial study due to their 
small size, despite the use of TEE in the initial assess-
ment of 7 out of 9 patients with repeat studies. 
Association between IE causing organisms and 
specific findings on echocardiography
The ability to infer on a specific organism based on 
findings on echocardiography is not well studied. While 
numerous studies on IE have identified the spectrum 
of involved organisms, most of them did not precisely 
analyse the association between echocardiographic 
findings and identified organisms [3, 24–26]. A recent 
international prospective study demonstrated that the 
sites infected with SA and the echocardiographic find-
Figure 3
Spectrum of echocardiographic findings in infective endocarditis. Illustration of the heterogeneous appearances of infective endocarditis specific 
echocardiographic findings caused by the same microorganism (panel 1A/B, 2A/B and 3A/B), and the homogenous appearances of findings caused 
by different microorganisms (panel 4A/B). * = septic aneurysm of the anterior mitral leaflet; Staph = Staphylococcus; P1 = segment P1 of the 
posterior mitral leaflet; A1 = segment A1 of the anterior mitral leaflet; Enterococcus f = Enterococcus faecalis; St = Streptococcus; Coagulase neg S 
= Coagulase negative staphylococcus; LCC and RCC = left and right coronary cusp, respectively; AV = aortic valve.
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treatment before confirmation of IE by echocardiogra-
phy did not influence outcome. Therefore, deferring the 
initial echocardiographic assessment for a few days ap-
pears to be safe. Most importantly, this holds true only 
as long as patients are clinically stable and adequately 
treated for potential IE. Deferring the confirmation of 
IE by echocardiography needs to be weighed against 
the eventually unnecessary exposure to potentially 
harmful antibiotic treatment. The optimal timing for 
echocardiographic assessment therefore remains a de-
cision based on individual clinical factors.
The goal of early diagnosis of IE is improving pa-
tient outcome. Assuming optimal timing of the initial 
echocardiographic assessment, it is important to re-
member which questions can be answered by echocar-
diography. Echocardiography is key for confirmation of 
IE and detecting complications at the valvular level 
that may influence management decisions such as tim-
ing of surgery or length of antibiotic treatment [3, 8]. 
However, as emphasised by our study, echocardiogra-
phy does not allow inference on the IE causing micro-
organisms. This limitation of echocardiography is im-
portant to realise, since long-time survival of patients 
depends on early and targeted antibiotic treatment [4]. 
On the other hand, our study demonstrates that many 
of the clinical findings differed significantly between 
SA and non-SA patients. Therefore, a precise patient 
history, including assessment of risk factors for IE, and 
a meticulous physical examination to detect vascular 
and immunologic complications may give early clues on 
the microorganism involved and are a valuable guide 
for the choice of empiric antibiotic treatment. 
Limitations
This analysis has the limitations associated with retro-
spective studies. In order to best assess the optimal 
timing for the echocardiographic detection of IE spe-
cific alterations, a prospective study with multiple re-
peat echocardiographic assessments before and during 
AB treatment would be necessary. However, since TEE 
is associated with (an albeit low) morbidity and mortal-
ity risk [30], multiple repetitive studies would be diffi-
cult to justify in view of the current literature. 
When dividing our population in SA and non-SA 
patients, we included culture negative patients in the 
group of non-SA patients. We may have unintention-
ally mixed unidentified SA patients with the non-SA 
patients. If so, this did not have a relevant impact on 
results. When we analysed the culture negative group 
separately, it did not differ significantly from the non-
SA group. 
In this study we did not make a distinction be-
tween the echocardiographic modalities used. TEE, for 
example, is known to have higher sensitivity for detec-
tion of paravalvular abscess formation and prosthetic 
valve endocarditis [31, 32]. The modality used in a 
given patient represented the optimal choice for deci-
sion making in the specific situation. However, we can-
not exclude that using TEE in each patient might have 
slightly altered our results. 
Our outcome data are limited despite the long pe-
riod of time covered by this study. Over the 16 years of 
the study duration, diagnostic accuracy as well as ther-
apeutic strategies have changed. Furthermore, there 
have been changes in clinical consultants and cardiac 
surgeons during the study period, potentially influenc-
ing management strategies and 
outcome. The (relatively few) 
changes in echocardiographers in-
volved may have influenced the ac-
curacy of the operator dependent 
TTE and TEE. Finally, the influ-
ence of new surgical strategies, 
new antibiotics or new resistance 
patterns to antibiotics has not been 
studied.
Conclusions
In patients with infective endocar-
ditis, the findings of early vs late 
initial echocardiographic assess-
ment did not differ. Echocardio-
graphic findings of infective endo-
carditis did not allow inference on 
the causing organism. Neither the 
timing of the initial echocardio-
graphic study nor any organism in-
volved was associated with clinical 
outcome.
Table 3
Analysis of early versus late initial echocardiographic assessment.
Initial echocardiography  
after antibiotic treatment of
  
p  
≤2 days 
(n = 119)*
>2 days
(n = 144)*
Time of antibiotic therapy to echo, days 1 (0–2) 9 (3–50) <0.001
Staphylococcus aureus endocarditis, n (%) 32 (27) 51 (35) 0.14
Vegetations, n (%) 108 (91) 124 (86) 0.25
Vegetation size (cm) 1.5 ± 0.7 1.5 ± 0.8 0.83
Paravalvular abscess, n (%) 28 (24) 35 (24) 0.88
Valve destruction, n (%) 52 (44) 51 (35) 0.17
New insufficiency ≥ moderate, n (%) 94 (79) 110 (76) 0.62
Native valve endocarditis, n (%) 100 (84) 114 (79) 0.31
Repaired mitral valve endocarditis, n (%) 3 (3) 6 (4) 0.47
Prosthetic valve endocarditis, n (%) 19 (16) 32 (22) 0.20
Pacemaker lead endocarditis, n (%) 2 (2) 4 (3) 0.55
Heart surgery for endocarditis, n (%) 72 (61) 76 (53) 0.21
In-hospital death due to endocarditis, n (%) 10 (8) 16 (11) 0.46
* In 11 patients, the time of antibiotic treatment before the initial echocardiography 
could not be reconstructed.
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